Fox Run Management, L.L.C. Laboratory Corp Of America Holdings Transaction History

Fox Run Management, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$203.72 - $248.97 $129,158 - $157,846	634 Added 46.79%	1,989 $468,000
Q3 2022 Nov 07, 2022	BUY	$204.81 - $262.19 $277,517 - $355,267	1,355 New	1,355 $278,000
Q1 2022 May 10, 2022	SELL	$259.82 - $298.18 $262,678 - $301,459	-1,011 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$271.6 - $314.21 $42,369 - $49,016	-156 Reduced 13.37%	1,011 $318,000
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $320,714 - $359,832	1,167 New	1,167 $328,000
Q2 2019 Jul 17, 2019	SELL	$144.16 - $172.9 $550,691 - $660,478	-3,820 Closed	0 $0
Q1 2019 Oct 17, 2019	BUY	$123.7 - $156.3 $216,846 - $273,993	1,753 Added 84.81%	3,820 $584,000
Q4 2018 Jan 15, 2019	BUY	$120.82 - $174.09 $249,734 - $359,844	2,067 New	2,067 $261,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.